Variation in Medical Costs for HIV Care Across the U.S.

A study of HIV+ persons at U.S. research sites showed a wider range of costs for those on ART, those off ART with CD4+ T cell counts <200 cells/mm³, drug injectors, and those seen in the South.

HIV care is expensive for various reasons, particularly the high cost of HIV drugs in the U.S. Because of reports of variability in costs across the U.S., investigators estimated the quarterly mean costs of care for 40,022 patients (mean age, 39) followed at 17 HIV Research Network sites across the country and then used quantile regression to highlight differences in the effect of key factors within each patient group.

The mean quarterly costs of care were highest for people living with HIV (PWH) and advanced disease who inject drugs (CD4 <200 cells/mm³) and for those receiving ART. Among patient subgroups, the greatest range in cost was found for PWH on ART, PWH off ART and with CD4 counts of either 200 to 499 cells/mm³ or <200 cells/mm³, P…

Reviewing Author

Keith Henry, MD

Disclosures

Consultant/Advisory BoardViiV Advisory Board

Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes

Keith Henry, MD

Disclosures

Consultant/Advisory BoardViiV Advisory Board

Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes

Variation in Medical Costs for HIV Care Across the U.S.

Topics

Reviewing Author